The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells
2006

c-Mpl as a Marker for Human Stem Cells

Sample size: 22 publication 10 minutes Evidence: high

Author Information

Author(s): Ninos John M, Jefferies Leigh C, Cogle Christopher R, Kerr William G

Primary Institution: H. Lee Moffitt Cancer Center and Research Institute

Hypothesis

The TPO receptor, c-mpl, is a selective surface marker for human hematopoietic stem cells.

Conclusion

The study shows that c-mpl is expressed at the highest levels on the most primitive human hematopoietic stem cells, indicating its potential as a marker for identifying and isolating these cells.

Supporting Evidence

  • c-mpl expression was highest in the most primitive stage I HSC/PC across all tissue sources.
  • The percentage of c-mpl+ cells decreased significantly from stage I to stage IV.
  • c-mpl+ cells showed higher levels of donor HLA+ thymocyte reconstitution compared to c-mpl- cells.

Takeaway

Scientists found that a special marker called c-mpl is found mostly on the earliest and most important blood-making cells in humans, which helps in understanding how to find and use these cells for treatments.

Methodology

Flow cytometry was used to analyze c-mpl expression in different stages of human CD34+ hematopoietic stem/progenitor cells from various sources.

Limitations

The study did not explore the functional differences between c-mpl+ and c-mpl- cells in detail.

Participant Demographics

Human samples were obtained from fetal liver, umbilical cord blood, adult bone marrow, and mobilized peripheral blood stem cells.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1479-5876-4-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication